& Co. and Ridgeback Biotherapeutics LP that is also under review by the FDA. The U.S. has agreed to purchase 3.1 million courses of molnupiraivir for about $2.2 billion.in the treatment of Covid-19. People would take the therapies at home shortly after they first develop symptoms to be able to keep them from becoming hospitalized. Covid-19 antibody therapies cleared for use are largely administered in hospitals and physicians’ offices or given to patients with advanced forms of the disease.
“My administration is making the necessary preparations now to ensure these treatments will be easily accessible and free,” Mr. Biden said. “This is positive news. This treatment could prove to be another critical tool in our arsenal that will accelerate our path out of the pandemic.”
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 live updates: 21 states see at least 10% jump in daily casesNEW: Pfizer has asked the FDA to authorize its COVID-19 pill, the company has announced in a press release. Both Merck and Pfizer are working on pills that appear very effective at keeping patients out of the hospital, according to the companies.
Source: ABC - 🏆 471. / 51 Read more »
U.S. expected to purchase 10 million courses of Pfizer COVID-19 pill - WaPoEarlier this month, Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, said the pill https://reut.rs/3oxaxnz cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial. Pfizer expects to submit interim trial results for the pill, branded Paxlovid, to the Food and Drug Administration (FDA) before the Nov. 25 U.S. Thanksgiving holiday. Tax dollars just bought 10M doses of experimental drugs. When did we become an investment partner in Pfizer-Mectin?
Source: YahooNews - 🏆 380. / 59 Read more »
Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world: This is a good move For unfortunately the world getting frustrating because of the pandemic which everybody known that it engineered through the Chinese laboratory 🧪
Source: WebMD - 🏆 709. / 51 Read more »